Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abiomed Inc
(NQ:
ABMD
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 21, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abiomed Inc
< Previous
1
2
3
4
5
Next >
Risk Vs Reward Vs Folly: Navigating Investment Choices
September 29, 2023
During the dot-com era, many individuals ridiculed Buffett for his refusal to invest in ventures that contradicted his principles. Years later, the majority of these so-called experts, if not all of...
Via
Talk Markets
Is It Too Late to Buy Johnson & Johnson's Stock?
April 28, 2023
This healthcare juggernaut's recent quarterly results prove just how strong its business is.
Via
The Motley Fool
2 Best Buffett Stocks to Buy for the Long Haul
December 27, 2022
Both of these stocks look like bargains right now.
Via
The Motley Fool
FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial
December 21, 2022
From
Abiomed, Inc.
Via
Business Wire
If You Invested $100 In This Stock 10 Years Ago, You Would Have $2,800 Today
December 08, 2022
Via
Benzinga
Here's How Much You Would Have Made Owning Abiomed Stock In The Last 15 Years
November 21, 2022
Via
Benzinga
Will Investors Notice Exciting Sign On Abiomed's Chart?
November 16, 2022
Via
Benzinga
Interest Rate Hikes Won't Stop These 2 Cash-Rich Growth Stocks
December 21, 2022
Even if interest rates go up, you likely won't need to worry about these stocks.
Via
The Motley Fool
The Best Stocks to Invest $20,000 in Right Now
December 21, 2022
The investments you make now could power your portfolio returns for years to come.
Via
The Motley Fool
Warren Buffett Loves These Stocks. Should You Buy Them Before 2023?
December 16, 2022
There's a lot more ahead for these market giants.
Via
The Motley Fool
Pfizer, Novartis Are Among Overbought Healthcare Stocks: Are They Worth A Look?
December 14, 2022
The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies. Here’s the latest list of major overbought players in this sector, with an RSI...
Via
Benzinga
2 Top Dividend Kings to Buy for the Long Haul
December 14, 2022
No matter how much changes, these two healthcare giants keep performing.
Via
The Motley Fool
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
December 09, 2022
Large-cap pharmaceuticals Pfizer and Johnson & Johnson are outperforming the broader market in the past year, particularly in the past three months.
Via
MarketBeat
This Monster Dividend Stock Isn't Done Growing
December 08, 2022
Is another deal on the way for Johnson & Johnson?
Via
The Motley Fool
Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi
December 05, 2022
There are now two companies in the ring for a Horizon takeover.
Via
Investor's Business Daily
First Patients in the World Treated with Impella RP Flex with SmartAssist
December 05, 2022
From
Abiomed, Inc.
Via
Business Wire
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
December 02, 2022
This space is ripe with opportunities for investors.
Via
The Motley Fool
Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout
November 30, 2022
Via
Benzinga
Bear Market Blues? 3 of the Best Stocks to Own in 2023
November 19, 2022
2023 could be a big year for each of these healthcare companies.
Via
The Motley Fool
Peering Into Abiomed's Recent Short Interest
November 17, 2022
Abiomed's (NASDAQ:ABMD) short percent of float has risen 6.62% since its last report. The company recently reported that it has 2.08 million shares sold short, which is 5.96% of all regular shares that...
Via
Benzinga
ABIOMED INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abiomed, Inc. - ABMD
November 16, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
S&P 500 Component DexCom Set For Further Price, Earnings Growth
November 13, 2022
Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
2 Warren Buffett Passive Income Stocks You Can Buy to Boost Your Yield
November 11, 2022
Buffett loves stocks that pay dividends. Is it any wonder Berkshire Hathaway is poised to collect more than $6 billion worth of them next year?
Via
The Motley Fool
Better Buy: Johnson & Johnson vs. Abbott Laboratories
November 10, 2022
These two healthcare giants are among the safest stocks investors can buy right now.
Via
The Motley Fool
Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed
November 10, 2022
The company is planting seeds for future growth.
Via
The Motley Fool
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Oyster Point Pharma, Inc. (Nasdaq - OYST), Benefitfocus, Inc. (Nasdaq - BNFT), Abiomed, Inc. (Nasdaq - ABMD), Atlas Corp. (NYSE - ATCO)
November 08, 2022
From
Brodsky & Smith LLC
Via
GlobeNewswire
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
November 08, 2022
These robust businesses will be around well beyond the next 10 years.
Via
The Motley Fool
3 No-Brainer Stocks to Buy in a Downturn
November 08, 2022
These companies thrive when others falter.
Via
The Motley Fool
Johnson & Johnson's Big Purchase, Amazon's New Moves, and More
November 05, 2022
Plus, we run through some shortcuts that could help you with your financial planning.
Via
The Motley Fool
Is Johnson & Johnson's Purchase of Abiomed Good for Investors?
November 05, 2022
The $16.6 billion acquisition shakes up MedTech.
Via
The Motley Fool
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.